Radical generation and alterations of erythrocyte integrity as bioindicators of diagnostic or prognostic value in COPD?

Antioxidants & Redox Signaling
Maurizio MinettiWalter Malorni

Abstract

Chronic obstructive pulmonary disease (COPD) has recently been viewed as an inflammation-dependent systemic disease. Oxidative modifications in the pulmonary microenvironment can result in a number of functional changes in pulmonary tissue as well as in the blood. Studies have been carried out to detect whether oxidatively modified molecules or cells could be considered possible markers of the disease. We hypothesize here that new insights into COPD could come from enzymes involved in deliberate radical generation (i.e., Nox and NOS family enzymes) as well as from alterations of erythrocyte integrity and function, which could become bioindicators of diagnostic or prognostic value in the near future.

References

Jan 1, 1981·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·H LandgrafG Fischer
May 1, 1995·Free Radical Biology & Medicine·V L van AntwerpenR Anderson
Nov 1, 1993·The American Review of Respiratory Disease·E M DrostW MacNee
May 28, 1993·Annals of the New York Academy of Sciences·W A Pryor, K Stone
Oct 1, 1996·American Journal of Respiratory and Critical Care Medicine·I RahmanW MacNee
Dec 31, 1997·American Journal of Respiratory and Critical Care Medicine·S PetruzzelliC Giuntini
Dec 18, 1998·Science·M Wills-KarpD D Donaldson
Aug 10, 2000·American Journal of Respiratory and Critical Care Medicine·P ParediP J Barnes
Sep 16, 2000·American Journal of Respiratory and Critical Care Medicine·P MontuschiP J Barnes
Dec 6, 2000·The Journal of Experimental Medicine·Z WangJ A Elias
Dec 19, 2000·Biochemical and Biophysical Research Communications·E StrafaceW Malorni
Apr 5, 2001·Trends in Molecular Medicine·W MacNee, I Rahman
Jul 19, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Adam E MullickJohn C Rutledge
Mar 12, 2003·Chest·Jack A EliasZhou Zhu
Mar 12, 2003·Chest·Richard J Martin, Monica Kraft
Apr 1, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Martin Götte
May 10, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Trevor T HanselPeter J Barnes
Jun 21, 2003·American Journal of Respiratory Cell and Molecular Biology·Esther BarreiroSabah N A Hussain
Jun 26, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Miklós GeisztThomas L Leto
Jul 12, 2003·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Bernard Lassègue, Roza E Clempus
Oct 30, 2003·The European Respiratory Journal·P J BarnesR A Pauwels
Mar 25, 2004·Nature Reviews. Immunology·J David Lambeth
May 19, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Andrzej SobczakKrzysztof Pawlicki
Aug 3, 2004·Nature Reviews. Immunology·Thomas A Wynn
Jan 15, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Paola MatarreseWalter Malorni
Apr 26, 2005·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·M C SantosA Bugalho De Almeida
Jun 29, 2005·The Journal of Biological Chemistry·Sean Y KassimJay W Heinecke
Jul 5, 2005·The European Respiratory Journal·C BrindicciS A Kharitonov
Jul 27, 2005·Cell Biochemistry and Biophysics·Blanca Camoretti-Mercado, Julian Solway
Aug 16, 2005·Chest·Masanori AsadaHidetada Sasaki
Oct 1, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Peter Bradding
Nov 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yukio IshiiKiyohisa Sekizawa
Nov 18, 2005·Pulmonary Pharmacology & Therapeutics·S AlpA Bastian
Feb 4, 2006·Current Opinion in Pulmonary Medicine·Vijay P Balasubramanian, Basil Varkey
Feb 9, 2006·European Journal of Pharmacology·Fabio L M RicciardoloGert Folkerts
Jun 22, 2006·Current Drug Targets·Irfan Rahman, Iain Kilty
Aug 16, 2006·Clinical and Experimental Immunology·B BarcelóA G N Agustí
Aug 17, 2006·Antioxidants & Redox Signaling·Maurizio Minetti, Walter Malorni
Sep 22, 2006·Antioxidants & Redox Signaling·Thomas L Leto, Miklos Geiszt
Oct 21, 2006·The Journal of Clinical Investigation·Xuchen ZhangPatty J Lee
Oct 27, 2006·Proceedings of the American Thoracic Society·Peter M HensonIvor S Douglas
Nov 4, 2006·American Journal of Respiratory and Critical Care Medicine·Patryk MoskwaBotond Bánfi

❮ Previous
Next ❯

Citations

Dec 21, 2011·Biochimica Et Biophysica Acta·Lucia CiccoliJoussef Hayek
Sep 8, 2009·Experimental and Molecular Pathology·Javier de CastroJesús Sánchez-Yagüe
Feb 24, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Patricia Sánchez-RodríguezJesús Sánchez-Yagüe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.